Literature DB >> 31416814

The case for CAR T-cell therapy in follicular lymphomas.

Michael R Bishop1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31416814     DOI： 10.1182/blood.2019001843

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.

Authors:  Stefan Alig; Vindi Jurinovic; Mohammad Shahrokh Esfahani; Sarah Haebe; Verena Passerini; Johannes C Hellmuth; Erik Gaitzsch; William Keay; Natyra Tahiri; Anna Zoellner; Andreas Rosenwald; Wolfram Klapper; Harald Stein; Alfred Feller; German Ott; Annette M Staiger; Heike Horn; Martin L Hansmann; Christiane Pott; Michael Unterhalt; Christian Schmidt; Martin Dreyling; Ash A Alizadeh; Wolfgang Hiddemann; Eva Hoster; Oliver Weigert
Journal:  Blood Adv       Date:  2020-09-22

Review 2.  Novel Therapy Approaches to Follicular Lymphoma.

Authors:  Michael Northend; William Townsend
Journal:  Drugs       Date:  2021-03       Impact factor: 9.546

3.  Ibrutinib improves the efficacy of anti-CD19-CAR T-cell therapy in patients with refractory non-Hodgkin lymphoma.

Authors:  Meijing Liu; Haobin Deng; Juan Mu; Qing Li; Yedi Pu; Yili Jiang; Qi Deng; Zhengzi Qian
Journal:  Cancer Sci       Date:  2021-05-10       Impact factor: 6.716

4.  Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis.

Authors:  Lili Wang; Rukmini Bhardwaj; Howard Mostowski; Paul N Patrone; Anthony J Kearsley; Jessica Watson; Liang Lim; Jothir Pichaandi; Olga Ornatsky; Daniel Majonis; Steven R Bauer; Heba A Degheidy
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

Review 5.  Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Authors:  Scott R Goldsmith; Armin Ghobadi; John F DiPersio
Journal:  Front Oncol       Date:  2020-12-22       Impact factor: 6.244

Review 6.  CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.

Authors:  Massimo Martino; Filippo Antonio Canale; Caterina Alati; Iolanda Donatella Vincelli; Tiziana Moscato; Gaetana Porto; Barbara Loteta; Virginia Naso; Massimiliano Mazza; Fabio Nicolini; Andrea Ghelli Luserna di Rorà; Giorgia Simonetti; Sonia Ronconi; Michela Ceccolini; Gerardo Musuraca; Giovanni Martinelli; Claudio Cerchione
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.